← Evidence map

ArticleInternational journal of molecular sciences2023

Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.

Dana Hellmold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37240419